Health Economics and Reimbursement

Health Economics and Reimbursement

Committed to improving patient access to life-saving therapies

Many legislative issues affect the dialysis market – reimbursement, tax, trade and a variety of regulatory concerns. Baxter's Government Affairs and Public Policy (GAPP) teams work with lawmakers, governments and policymakers around the globe to support patient access to life-saving therapies, increase understanding of the benefits of those therapies, address barriers to care and explore possible solutions. This includes working directly with governments to improve the regulatory environment and reimbursement structure for all dialysis therapies, and collaborating with clinicians, non-governmental organizations and patient groups on other coordinated efforts to increase access to care for millions of patients around the world.